๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia

โœ Scribed by E. L. Prigogina; E. W. Fleischman; M. A. Volkova; M. A. Frenkel


Publisher
Springer
Year
1978
Tongue
English
Weight
650 KB
Volume
41
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

โœฆ Synopsis


Forty cases of chronic myeloid leukemia (CML) were studied and subgroups of cases with similar chromosomal abnormalities in terminal stage were defined. Certain correlations were observed between the type of chromosomal changes, and clinical and morphologic manifestations of the disease: (1) It seems that, in cases without any karyotype changes other than translocation (9;22), the terminal stage is longer and milder than in cases with additional chromosomal abnormalities; (2) cases with marker i(17q) are clinically and morphologically rather uniform and are characterized by distinct signs of myeloid differentiation of blast cells, absent in other cases; (3) in cases with various atypical chromosomal abnormalities, the course of the terminal stage is the most rapid and grave. The blast cells differ from myeloblasts and resemble lymphoid elements.


๐Ÿ“œ SIMILAR VOLUMES


Chromosome abnormalities, clinical and m
โœ ร‰va Olรคh; Attila Kiss; Jรกnos Jakq ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 660 KB

## Abstract Seventeen cases of chronic myeloid leukemia (CML) in metamorphosis have been investigated by cytogenetic methods. Six patients were studied in slow transformation and others in the terminal blastic phase of the disease. Of these, 3 cases were myeloid, 3 myelomonocytic, I megakaryoblasti

Correlation between CD34 expression and
โœ Fruchart, Christophe; Lenormand, Bernard; Bastard, Christian; Boulet, Dominique; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 482 KB ๐Ÿ‘ 2 views

The hemopoietic stem cell marker CD34 has been reported to be a useful predictor of treatment outcome in acute myeloid leukemia (AML). Previous data suggested that CD34 expression may be associated with other poor prognosis factors in AML such as undifferentiated leukemia, secondary AML (SAML), and